|
Press Releases |
|
 |
|
Tuesday, April 28, 2020 |
|
Novotech COVID-19 臨床試驗客戶受益於亞太地區新的快速審批流程 |
亞太地區最大的專業生物技術CRO Novotech表示,該地區的許多國家正在實行候選治療方法和疫苗快速審查流程,以便快速審批COVID-19 客戶的臨床試驗。 more info >> |
|
노보텍의 코로나19 임상시험 클라이언트, 아시아태평양 지역의 새로운 패스트트랙 심의과정의 혜택을 누리다 |
아시아·태평양 지역 최대의 바이오테크 전문 임상 시험 수탁 기관인 노보텍은 아·태 지역 내 많은 국가들이 치료제 및 백신 후보에 대한 신속 심의를 통해 클라이언트의 코로나19 임상시험을 신속하게 처리하기 위한 패스트트랙 절차를 실시하고 있다고 밝혔다. more info >> |
|
Wednesday, April 8, 2020 |
|
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity |
Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations. more info >> |
|
Friday, March 20, 2020 |
|
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials |
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist for two of the prestigious Citeline Awards 2020 (formerly CARE Awards) by Informa Pharma Intelligence. more info >> |
|
Tuesday, March 10, 2020 |
|
Novotech与科微范株式会社(Komipharm)签署CRO合同,在韩国进行新型冠状病毒肺炎临床试验 |
亚太地区最大的专业生物技术合同研究机构 Novotech已被科微范株式会社选定,对作为新型冠状病毒肺炎潜在治疗方案的Panaphix进行临床试验。 more info >> |
|
Novotech與科微範株式會社(Komipharm)簽署CRO合同,在韓國進行新型冠狀病毒肺炎臨床試驗 |
亞太地區最大的專業生物技術合同研究機構Novotech已被科微範株式會社選定,對作為新型冠狀病毒肺炎潛在治療方案的Panaphix進行臨床試驗。 more info >> |
|
Friday, March 6, 2020 |
|
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea |
Asia-Pacific's largest specialist biotech CRO Novotech has been selected for the Komipharm International clinical trials of Panaphix as a potential treatment for coronavirus - Covid-19. more info >> |
|
Tuesday, January 21, 2020 |
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
Thursday, July 11, 2019 |
|
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research |
Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials. more info >> |
|
Friday, May 31, 2019 |
|
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO |
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
エーザイとライフネット生命保険、生活者の医療・介護の負担軽減に向けたエコシステムの構築を目指す資本業務提携契約を締結
Aug 9, 2022 16:20: JST
|
|
|
日立と日立ビルシステム、「日本橋一丁目中地区第一種市街地再開発事業」向けの昇降機139台を一括受注
Aug 9, 2022 15:00: JST
|
|
|
Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully
Aug 9, 2022 13:06 HKT/SGT
|
|
|
ハピネスプラネットと日立、職場のメンタルリスク低減に向け、ハピネスアプリの活用による縦・横・斜めのコミュニケーションの改善を実証
Aug 9, 2022 13:00: JST
|
|
|
積水ハウスとNEC、集合住宅における顔認証システムを活用した取り組みにおいて連携
Aug 9, 2022 10:30: JST
|
|
|
捕捉港股业绩潜力股:顺丰同城多项指标第一
Aug 9, 2022 08:01 HKT/SGT
|
|
|
捕捉港股業績潛力股:順豐同城多項指標第一
Aug 9, 2022 08:00 HKT/SGT
|
|
|
Paribus: DeFi Protocol for Exotic Digital Assets
Aug 9, 2022 06:56 HKT/SGT
|
|
|
Crypto Exchange, JPEX Announces Launch of Native Token, JPC
Aug 8, 2022 23:00: JST
|
|
|
Crypto Exchange, JPEX Announces Launch of Native Token, JPC
Aug 8, 2022 23:00 HKT/SGT
|
|
|
双财庄有限公司公布于香港联交所主板上市计划详情
Aug 8, 2022 19:23 HKT/SGT
|
|
|
雙財莊有限公司公佈於香港聯交所主板上市計劃詳情
Aug 8, 2022 19:22 HKT/SGT
|
|
|
Swang Chai Chuan Limited Announces Details of Proposed Listing on the Main Board of The Stock Exchange of Hong Kong Limited
Aug 8, 2022 19:21 HKT/SGT
|
|
|
The 3rd Asia Digital Talent Summit 2022
Aug 8, 2022 19:00 HKT/SGT
|
|
|
HKTDC welcomes measures to ease quarantine restrictions
Aug 8, 2022 18:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|